Abstract：Chlamydia trachomatis (Ct) is an obligate intracellular pathogen. Effector proteins are secreted into host cells through the type III secretion system (T3SS). T3SS effector proteins play important roles in Ct development and interaction with host cells, such as regulating the host cell actin cytoskeleton, subverting immune signaling pathways and controlling apoptosis in host cells. This article reviews recent advances in research on Chlamydia trachomatis T3SS effector proteins.
张荣荣, 高哲, 贾天军. 沙眼衣原体III型分泌系统效应蛋白研究进展[J]. 中国人兽共患病学报, 2021, 37(1): 78-82.
ZHANG Rong-rong, GAO Zhe, JIA Tian-jun. Research progress on Chlamydia trachomatis type III secretion system effector proteins. Chinese Journal of Zoonoses, 2021, 37(1): 78-82.
[1] Starnbach MN.The well-evolved pathogen[J]. Curr Opin Microbiol, 2020, 54: 33-36. DOI: 10.1016/j.mib.2020.01.004 [2] Elwell C, Mirrashidi K, Engel J.Chlamydia cell biology and pathogenesis[J]. Nat Rev Microbiol, 2016, 14(6): 385-400. DOI: 10.1038/nrmicro.2016.30 [3] Mueller KE, Plano GV, Fields KA.New frontiers in type III secretion biology: the Chlamydia perspective[J]. Infect Immun, 2014, 82(1): 2-9. DOI: 10.1128/IAI.00917-13 [4] Betts-Hampikian HJ, Fields KA.The Chlamydial type III secretion mechanism: revealing cracks in a tough nut[J]. Front Microbiol, 2010, 1: 114. DOI: 10.3389/fmicb.2010.00114 [5] Galán JE, Lara-Tejero M, Marlovits TC, et al.Bacterial type III secretion systems: specialized nanomachines for protein delivery into target cells[J]. Annu Rev Microbiol, 2014, 68: 415-438. DOI: 10.1146/annurev-micro-092412-155725 [6] Hefty PS, Stephens RS.Chlamydial type III secretion system is encoded on ten operons preceded by sigma 70-like promoter elements[J]. J Bacteriol, 2007, 189(1): 198-206. DOI: 10.1128/JB.01034-06 [7] Bugalhäo JN, Mota LJ.The multiple functions of the numerous Chlamydia trachomatis secreted proteins: the tip of the iceberg[J]. Microb Cell, 2019, 6(9): 414-449. DOI: 10.15698/mic2019.09.691 [8] Dumoux M, Menny A, Delacour D, et al.A Chlamydia effector recruits CEP170 to reprogram host microtubule organization[J]. J Cell Sci, 2015, 128(18): 3420-3434. DOI: 10.1242/jcs.169318 [9] Filardo S, Skilton RJ, O’Neill CE, et al. Growth kinetics of Chlamydia trachomatis in primary human sertoli cells[J]. Sci Rep, 2019, 9(1): 5847. DOI: 10.1038/s41598-019-42396-3 [10] Wesolowski J, Weber MM, Nawrotek A, et al.Chlamydia hijacks ARF GTPases to coordinate microtubule posttranslational modifications and golgi complex positioning[J]. mBio, 2017, 8(3):e02280-16. DOI: 10.1128/mBio.02280-16 [11] Jewett TJ, Fischer ER, Mead DJ, et al.Chlamydial TARP is a bacterial nucleator of actin[J]. Proc Natl Acad Sci USA, 2006, 103(42): 15599-15604. DOI: 10.1073/pnas.0603044103 [12] Jiwani S, Ohr RJ, Fischer ER, et al.Chlamydia trachomatis Tarp cooperates with the Arp2/3 complex to increase the rate of actin polymerization[J]. Biochem Biophys Res Commun, 2012, 20(4): 816-821. DOI: 10.1016/j.bbrc.2012.03.080 [13] Ghosh S, Ruelke EA, Ferrell JC, et al.Fluorescence-reported allelic exchange mutagenesis-mediated gene deletion indicates a requirement for Chlamydia trachomatis tarp during in vivo infectivity and reveals a specific role for the C terminus during cellular invasion[J]. Infect Immun, 2020, 88(5): e00841-19. DOI: 10.1128/IAI.00841-19 [14] Clifton DR, Dooley CA, Grieshaber SS, et al.Tyrosine phosphorylation of the chlamydial effector protein Tarp is species specific and not required for recruitment of actin[J]. Infect Immun, 2005, 73(7): 3860-3868. DOI: 10.1128/IAI.73.7.3860-3868.2005 [15] Mueller KE, Fields KA.Application of β-lactamase reporter fusions as an indicator of effector protein secretion during infections with the obligate intracellular pathogen Chlamydia trachomatis[J]. PLoS One, 2015, 10(8): e0135295. DOI: 10.1371/journal.pone.0135295 [16] Keb G, Hayman R, Fields KA.Floxed-cassette allelic exchange mutagenesis enables markerless gene deletion in Chlamydia trachomatis and can reverse cassette-induced polar effects[J]. J Bacteriol, 2018, 200(24): e00479-18. DOI: 10.1128/JB.00479-18 [17] McKuen MJ, Mueller KE, Bae YS, et al. Fluorescence-reported allelic exchange mutagenesis reveals a role for Chlamydia trachomatis TmeA in invasion that is independent of host AHNAK[J]. Infect Immun, 2017, 85(12): e00640-17. DOI: 10.1128/IAI.00640-17 [18] Belland RJ, Scidmore MA, Crane DD, et al.Chlamydia trachomatis cytotoxicity associated with complete and partial cytotoxin genes[J]. Proc Natl Acad Sci U S A, 2001, 98(24): 13984-13989. DOI: 10.1073/pnas.241377698 [19] Thalmann J, Janik K, May M, et al.Actin re-organization induced by Chlamydia trachomatis serovar D-evidence for a critical role of the effector protein CT166 targeting Rac[J]. PLoS One, 2010, 5(3): e9887. DOI: 10.1371/journal.pone.0009887 [20] Pais SV, Milho C, Almeida F, et al.Identification of novel type III secretion chaperone-substrate complexes of Chlamydia trachomatis[J]. PLoS One, 2013, 8(2): e56292. DOI: 10.1371/journal.pone.0056292 [21] Chen YS, Bastidas RJ, Saka HA, et al.The Chlamydia trachomatis type III secretion chaperone Slc1 engages multiple early effectors, including TepP, a tyrosine-phosphorylated protein required for the recruitment of CrkI-II to nascent inclusions and innate immune signaling[J]. PLoS Pathog, 2014, 10: e1003954. DOI: 10.1371/journal.ppat.1003954 [22] Carpenter V, Chen YS, Dolat L, et al.The effector TepP mediates recruitment and activation of phosphoinositide 3-Kinase on early Chlamydia trachomatis vacuoles[J]. mSphere, 2017, 2(4): e00207-17. DOI: 10.1128/mSphere.00207-17 [23] Starnbach MN, Loomis WP, Ovendale P, et al.An inclusion membrane protein from Chlamydia trachomatis enters the MHC class I pathway and stimulates a CD8+T cell response[J]. J Immunol, 2003, 171(9): 4742-4749. DOI: 10.4049/jimmunol.171.9.4742 [24] Jia L, Sun F, Wang J, et al.Chlamydia trachomatis ct143 stimulates secretion of proinflammatory cytokines via activating the p38/MAPK signal pathway in THP-1 cells[J]. Mol Immunol, 2019, 105: 233-239. DOI: 10.1016/j.molimm.2018.12.007 [25] Ronzone E, Paumet F.Two coiled-coil domains of Chlamydia trachomatis IncA affect membrane fusion events during infection[J]. PLoS One, 2013, 8(7): e69769. DOI: 10.1371/journal.pone.0069769 [26] Banhart S, Rose L, Aeberhard L, et al.Chlamydia trachomatis and its interaction with the cellular retromer[J]. Int J Med Microbiol, 2018, 308(1): 197-205. DOI: 10.1016/j.ijmm.2017.10.006 [27] Faris R, Merling M, Andersen SE, et al.Chlamydia trachomatis CT229 subverts rab GTPase-dependent CCV trafficking pathways to promote Chlamydial infection[J]. Cell Rep, 2019, 26(12): 3380-3390. DOI: 10.1016/j.celrep.2019.02.079 [28] Elwell CA, Jiang S, Kim JH, et al.Chlamydia trachomatis co-opts GBF1 and CERT to acquire host sphingomyelin for distinct roles during intracellular development[J]. PLoS Pathog, 2011, 7: e1002198. DOI: 10.1371/journal.ppat.1002198 [29] Kumagai K, Elwell CA, Ando S, et al.Both the N- and C- terminal regions of the Chlamydial inclusion protein D (IncD) are required for interaction with the pleckstrin homology domain of the ceramide transport protein CERT[J]. Biochem Biophys Res Commun, 2018, 505(4): 1070-1076. DOI: 10.1016/j.bbrc.2018.09.168 [30] Stanhope R, Flora E, Bayne C, et al.IncV, a FFAT motif-containing Chlamydia protein, tethers the endoplasmic reticulum to the pathogen-containing vacuole[J]. Proc Natl Acad Sci U S A, 2017, 114(45): 12039-12044. DOI: 10.1073/pnas.1709060114 [31] Pennini ME, Perrinet S, Dautry-Varsat A, et al.Histone methylation by NUE, a novel nuclear effector of the intracellular pathogen Chlamydia trachomatis[J]. PLoS Pathog, 2010, 6(7): e1000995. DOI: 10.1371/journal.ppat.1000995 [32] Kebbi-Beghdadi C, Pilloux L, Martin V, et al.Eukaryotic cell permeabilisation to identify new putative Chlamydial type III secretion system effectors secreted within host cell cytoplasm[J]. Microorganisms, 2020, 8(3): 361. DOI: 10.3390/microorganisms8030361 [33] Gong S, Lei L, Chang X, et al.Chlamydia trachomatis secretion of hypothetical protein CT622 into host cell cytoplasm via a secretion pathway that can be inhibited by the type III secretion system inhibitor compound 1[J]. Microbiology, 2011, 157(4): 1134-1144. DOI: 10.1099/mic.0.047746-0 [34] Cossé MM, Barta ML, Fisher DJ, et al.The loss of expression of a single type 3 effector (CT622) strongly reduces Chlamydia trachomatis infectivity and growth[J]. Front Cell Infect Microbiol, 2018,8:145.DOI: 10.3389/fcimb.2018.00145 [35] Nguyen UT, Goody RS, Alexandrov K.Understanding and exploiting protein prenyltransferases[J]. Chembiochem, 2010, 11(9): 1194-1201. DOI: 10.1002/cbic.200900727 [36] Lutter EI, Barger AC, Nair V, et al.Chlamydia trachomatis inclusion membrane protein CT228 recruits elements of the myosin phosphatase pathway to regulate release mechanisms[J]. Cell Rep, 2013, 3(6): 1921-1931. DOI: 10.1016/j.celrep.2013.04.027 [37] Nguyen PH, Lutter EI, Hackstadt T.Chlamydia trachomatis inclusion membrane protein MrcA interacts with the inositol 1,4,5-trisphosphate receptor type 3 (ITPR3) to regulate extrusion formation[J]. PLoS Pathog, 2018, 14: e1006911. DOI: 10.1371/journal.ppat.1006911 [38] Sixt BS, Bastidas RJ, Finethy R, et al.The Chlamydia trachomatis inclusion membrane protein CpoS counteracts STING-Mediated cellular surveillance and suicide programs[J]. Cell Host Microbe, 2017, 21(1): 113-121. DOI: 10.1016/j.chom.2016.12.002 [39] Weber MM, Lam JL, Dooley CA, et al.Absence of specific Chlamydia trachomatis inclusion membrane proteins triggers premature inclusion membrane lysis and host cell death[J]. Cell Rep, 2017, 19(7): 1406-1417. DOI: 10.1016/j.celrep.2017.04.058 [40] Beeckman DS, Geens T, Timmermans JP, et al.Identification and characterization of a type III secretion system in Chlamydophila psittaci[J]. Vet Res, 2008, 39(3): 27. DOI: 10.1051/vetres:2008002 [41] Stenner-Liewen F, Liewen H, Zapata JM, et al.CADD, a Chlamydia protein that interacts with death receptors[J]. J Biol Chem, 2002, 277(12): 9633-9636. DOI: 10.1074/jbc.C100693200 [42] Valdivia RH.Chlamydia effector proteins and new insights into chlamydial cellular microbiology[J]. Curr Opin Microbiol, 2008, 11(1): 53-59. DOI: 10.10 16/j.mib.2008.01.003
2021, Vol. 37 
